Registered Owners
- View profile →
PT SIMEX PHARMACEUTICAL INDONESIA
Kota Jakarta Utara, DKI Jakarta, Indonesia
NPWP: 020390134046000
owner
Traditional MedicineValid (Supersedes Previous)
MAXIGLUTA
- BPOM Number
- SD255059151
- Approved
- 22 September 2025
- Expiry
- 30 July 2030
- Form
- Tablet
About This Registration
MAXIGLUTA is a BPOM-registered traditional medicine in Indonesia, registered under number SD255059151. Its current registration status is Valid (Supersedes Previous), with the licence valid until 30 July 2030. The product is registered to PT SIMEX PHARMACEUTICAL INDONESIA. BPOM first approved this registration in July 2025. All registration data is sourced directly from the official BPOM public database and updated daily.
Registration Details
- Application
- e-Registration Obat Tradisional & Suplemen Kesehatan (ASROT)
- Packaging
- Dus, 3 strip @ 10 tablet
- Department
- Traditional Medicine, Health Supplements & Cosmetics Directorate
Retail Audit Service
Get detailed market intelligence for this product across Indonesian retail channels
Multiple cities available
Custom questionnaires
Professional shoppers
Detailed reporting
Starting from $50 per city
What's included in the audit service?
Stock availability and positioning verification
Price checking and competitor analysis
Display quality and promotional material assessment
Store condition and customer experience evaluation
Custom questions tailored to your research needs
Professional photographs and detailed reports
Manufacturing Sites
- View profile →
PT SIMEX PHARMACEUTICAL INDONESIA
Kota Jakarta Utara, DKI Jakarta, Indonesia
primary
Ingredients (1)
REDUCED L-GLUTATHIONE
Market Intelligence
- Owner Portfolio
- PT SIMEX PHARMACEUTICAL INDONESIA holds 58 BPOM registrations
- Manufacturer Scale
- PT SIMEX PHARMACEUTICAL INDONESIA produces 58 registered products
- Registration Age
- Registered for 1 year, 1 month
Is this your product?
Claim it to manage registration, track renewals, and get expiry alerts.